Sight Sciences Inc
For the period ended Dec 31, 2023. Filed Mar 13, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 13, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Indicates a management or compensatory plan.
- Portions of this exhibit are redacted in accordance with Item 601(b)(10)(iv) of Regulation S-K. The Company agrees to furnish an unredacted copy of such exhibit, or a copy of any omitted schedule or exhibit, to the SEC upon request.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| SIGHT SCIENCES, INC. | ||
| Date: March 12, 2024 | By: | /s/ Alison Bauerlein |
|---|---|---|
| Alison Bauerlein | ||
| Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.
| Name and Signature | Title | Date |
|---|---|---|
| /s/ Paul Badawi | President, Chief Executive Officer and Director | March 12, 2024 |
| Paul Badawi | (Principal Executive Officer) | |
| /s/ Alison Bauerlein | Chief Financial Officer (Principal Financial | March 12, 2024 |
| Alison Bauerlein | Officer and Principal Accounting Officer) | |
| /s/ Staffan Encrantz | Chairman of the Board of Directors | March 12, 2024 |
| Staffan Encrantz | ||
| /s/ David Badawi | Chief Technology Officer and Director | March 12, 2024 |
| David Badawi, M.D. | ||
| /s/ Tamara Fountain | Director | March 12, 2024 |
| Tamara Fountain, M.D. | ||
| /s/ Brenda Becker | Director | March 12, 2024 |
| Brenda Becker | ||
| /s/ Erica Rogers | Director | March 12, 2024 |
| Erica Rogers | ||
| /s/ Catherine Mazzacco | Director | March 12, 2024 |
| Catherine Mazzacco | ||
| /s/ Donald Zurbay | Director | March 12, 2024 |
| Donald Zurbay | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.